Prescription drug · ANDA
Perphenazine NDC 52536-164
Perphenazine 4 mg/1 · Tablet, Film coated · Oral · Wilshire Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52536-164-01 | 5253601640152536016401 | 100 TABLET, FILM COATED in 1 BOTTLE (52536-164-01)Marketed from Feb 6, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Perphenazine
- Generic name (nonproprietary)
- perphenazine
- Active ingredients
- Perphenazine — 4 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Wilshire Pharmaceuticals, Inc.NDC labeler code 52536
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205973
- Marketing start
- Listing expires
- Other FDA classes
- Phenothiazines (Chemical structure)
- Identifiers
- Product ID 52536-164_325b0584-e6f3-f087-e063-6394a90a64c5SPL ID 325b0584-e6f3-f087-e063-6394a90a64c5SPL set ID 5e455842-4892-4795-8c9b-4109a8f30783RxCUI 198075, 198076, 198077, 198078UNII FTA7XXY4EZ
- Pharmacologic class
- Phenothiazine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452536016401followed by a unit qualifier and the quantityPackage 52536-0164-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation.
Excerpt only. Read the full label for complete information.
About NDC 52536-164
- What is NDC 52536-164?
- 52536-164 is the product NDC for Perphenazine, Perphenazine 4 mg/1 tablet, film coated, listed with the FDA by Wilshire Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Perphenazine.
- What is the active ingredient?
- Perphenazine.
- Who is the labeler?
- Wilshire Pharmaceuticals, Inc., NDC labeler code 52536. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Perphenazine?
- 72 other product NDCs are listed under this name. See all Perphenazine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Perphenazine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Perphenazine | Perphenazine 2 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4688 | 70518-4688-00 |
| Perphenazine | Perphenazine 16 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4484 | 70518-4484-0070518-4484-02 |
| Perphenazine | Perphenazine 16 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4144 | 70518-4144-00 |
| Perphenazine | Perphenazine 4 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4112 | 70518-4112-00 |
| Perphenazine | Perphenazine 4 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-449 | 33342-0449-1133342-0449-15 |
| Perphenazine | Perphenazine 2 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-448 | 33342-0448-1133342-0448-15 |
| Perphenazine | Perphenazine 8 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-450 | 33342-0450-1133342-0450-15 |
| Perphenazine | Perphenazine 16 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-451 | 33342-0451-1133342-0451-15 |
| Perphenazine | Perphenazine 4 mg/1 | TabletOral | Chartwell RX, LLC | 62135-799 | 62135-0799-90 |
| Perphenazine | Perphenazine 2 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-799 | 23155-0799-01 |
Other NDCs under ANDA 205973
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Perphenazine | Perphenazine 2 mg/1 | Tablet, Film coatedOral | Wilshire Pharmaceuticals, Inc. | 52536-162 |
| Perphenazine | Perphenazine 8 mg/1 | Tablet, Film coatedOral | Wilshire Pharmaceuticals, Inc. | 52536-168 |
| Perphenazine | Perphenazine 16 mg/1 | Tablet, Film coatedOral | Wilshire Pharmaceuticals, Inc. | 52536-170 |
| Perphenazine | Perphenazine 16 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-1109 |
| Perphenazine | Perphenazine 4 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-1125 |
| Perphenazine | Perphenazine 8 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-1133 |
| Perphenazine | Perphenazine 8 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-2893 |
| Perphenazine | Perphenazine 2 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2396 |
| Perphenazine | Perphenazine 4 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2397 |
| Perphenazine | Perphenazine 8 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2398 |
| Perphenazine | Perphenazine 16 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2399 |